IPOs

Moderna’s Billions: Will Building Big Before an IPO Pay Off?
Moderna’s Billions: Will Building Big Before an IPO Pay Off?
Xconomy
Merck
Moderna Therapeutics
IPOs
Flag link:
Autolus seeks $100M IPO to take next-gen CAR-Ts deep into the clinic
Autolus seeks $100M IPO to take next-gen CAR-Ts deep into the clinic
Fierce Biotech
IPOs
Autolus
CAR-T
clinical trials
Flag link:
Positive first IPO results from Sweden’s Immunovia
Positive first IPO results from Sweden’s Immunovia
GoinPharma
IPOs
Immunovia
Flag link:
Alzheon steps back from an IPO, further than ever from a PhIII Alzheimer’s study
Alzheon steps back from an IPO, further than ever from a PhIII Alzheimer’s study
Endpoints
Alzheon
Alzheimer's disease
clinical trials
ALZ-801
IPOs
Flag link:
Innovent Biologics Takes in $150 million in Series E Round - May Drop U.S. IPO Plans
Innovent Biologics Takes in $150 million in Series E Round - May Drop U.S. IPO Plans
CP Wire
Innovent Biologics
IPOs
Flag link:
Surface Oncology Banks $119.5 Million With IPO and Private Placement
Surface Oncology Banks $119.5 Million With IPO and Private Placement
CP Wire
Surface Oncology
IPOs
Flag link:
In knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
In knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
Endpoints
IPOs
MorphoSys
Surface Oncology
NASDAQ
Flag link:
Inspire Medical plans $86m IPO
Inspire Medical plans $86m IPO
Mass Device
Inspire Medical
Medtronic
obstructive sleep apnea
IPOs
devices
Flag link:
Leap of faith? Buzzy anti-aging biotech Unity pitches an $85M IPO based on mouse data
Leap of faith? Buzzy anti-aging biotech Unity pitches an $85M IPO based on mouse data
Endpoints
Unity Biotechnology
IPOs
Flag link:
Unity Biotech Files IPO to Bring Anti-Aging Drugs into Clinical Trials
Unity Biotech Files IPO to Bring Anti-Aging Drugs into Clinical Trials
Xconomy
Unity Biotechnology
IPOs
osteoarthritis
Flag link:
Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies
Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies
Xconomy
Unum Therapeutics
cell therapy
IPOs
Flag link:
No Data Yet, But Homology Upsizes IPO and Raises $144M
No Data Yet, But Homology Upsizes IPO and Raises $144M
Xconomy
Homology Med
IPOs
gene editing
Flag link:
Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug
Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug
Xconomy
Alzheon
Alzheimer's disease
IPOs
ALZ-801
Flag link:
Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold
Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold
Endpoints
Unum
IPOs
cell therapy
FDA
Flag link:
Grey Hair In the C-Suite: Experience, Age, And IPOs In Biotech
Grey Hair In the C-Suite: Experience, Age, And IPOs In Biotech
Forbes
biotech
executives
age
IPOs
Flag link:
Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment
Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment
Forbes
Genprex
IPOs
gene therapy
lung cancer
Flag link:
Nasdaq Exec 'Even More Bullish' On Biotech IPOs As New Entries Soar
Nasdaq Exec 'Even More Bullish' On Biotech IPOs As New Entries Soar
Forbes
biotech
NASDAQ
IPOs
ARMO BioSciences
Menlo Therapeutics
Cue Biopharma
Flag link:
Dermapharm targets $1bn IPO before end of quarter
Dermapharm targets $1bn IPO before end of quarter
GoinPharma
Dermapharm
IPOs
Flag link:
Boasting a late-stage Botox me-too, Evolus files for $75M IPO
Boasting a late-stage Botox me-too, Evolus files for $75M IPO
Endpoints
Evolus
Botox
Allergan
IPOs
DWP-450
biosimilars
Flag link:
A Biotech VC's Outlook For 2018
A Biotech VC's Outlook For 2018
Forbes
biotech
venture capital
venture
M&A
IPOs
Flag link:

Pages